Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups

Paterson, 2000, Neuronal nicotinic receptors in the human brain, Prog. Neurobiol., 61, 75, 10.1016/S0301-0082(99)00045-3 Nielsen, 2019, Flavonoids as positive allosteric modulators of alpha7 nicotinic receptors, Neuropharmacology, 160, 107794, 10.1016/j.neuropharm.2019.107794 Karlin, 1983, The arrangement of the subunits of the acetylcholine receptor of Torpedo californica, J. Biol. Chem., 258, 6678, 10.1016/S0021-9258(18)32266-X Unwin, 2013, Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranes, Q. Rev. Biophys., 46, 283, 10.1017/S0033583513000061 Mishina, 1986, Molecular distinction between fetal and adult forms of muscle acetylcholine receptor, Nature, 321, 406, 10.1038/321406a0 Witzemann, 1987, Differential regulation of muscle acetylcholine receptor γ-and ε-subunit mRNAs, FEBS Lett., 223, 104, 10.1016/0014-5793(87)80518-5 Hunter, 2017, Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation, Br. J. Anaesth., 119, i53, 10.1093/bja/aex318 Lerch, 2016, Emerging targets in photopharmacology, Angew. Chem., Int. Ed. Engl., 55, 10978, 10.1002/anie.201601931 Nayak, 2014, Functional differences between neurotransmitter binding sites of muscle acetylcholine receptors, Proc. Natl. Acad. Sci. U.S.A., 111, 17660, 10.1073/pnas.1414378111 Cecchini, 2015, The nicotinic acetylcholine receptor and its prokaryotic homologues: structure, conformational transitions & allosteric modulation, Neuropharmacology, 96, 137, 10.1016/j.neuropharm.2014.12.006 Bowman, 2006, Neuromuscular block, Br. J. Pharmacol., 147, S277, 10.1038/sj.bjp.0706404 Farooq, 2017, Neuromuscular blocking agents and reversal agents, Anaesth. Intensive Care Med., 18, 279, 10.1016/j.mpaic.2017.03.007 Bartels, 1971, Photochromic activators of the acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A., 68, 1820, 10.1073/pnas.68.8.1820 Nerbonne, 1983, cis-3, 3’-Bis-[alpha-(trimethylammonium) methyl] azobenzene (cis-Bis-Q). Purification and properties at acetylcholine receptors of Electrophorus electroplaques, Mol. Pharmacol., 23, 344 Gomez-Santacana, 2017, Positional isomers of bispyridine benzene derivatives induce efficacy changes on mGlu5 negative allosteric modulation, Eur. J. Med. Chem., 127, 567, 10.1016/j.ejmech.2017.01.013 Rastogi, 2018, Photoresponsive azo-combretastatin A-4 analogues, Eur. J. Med. Chem., 143, 1, 10.1016/j.ejmech.2017.11.012 Lutz, 2018, Development of new photoswitchable azobenzene based γ-aminobutyric acid (GABA) uptake inhibitors with distinctly enhanced potency upon photoactivation, J. Med. Chem., 61, 6211, 10.1021/acs.jmedchem.8b00629 Leippe, 2018, Optical control of a delayed rectifier and a two-pore potassium channel with a photoswitchable bupivacaine, ACS Chem. Neurosci., 9, 2886, 10.1021/acschemneuro.8b00279 Ferreira, 2015, Design, synthesis and inhibitory activity of photoswitchable RET kinase inhibitors, Sci. Rep., 5, 9769, 10.1038/srep09769 Hoorens, 2019, Light-controlled inhibition of BRAFV600E kinase, Eur. J. Med. Chem., 179, 133, 10.1016/j.ejmech.2019.06.042 Pittolo, 2019, Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology, Proc. Natl. Acad. Sci. U.S.A., 116, 13680, 10.1073/pnas.1900430116 Ricart-Ortega, 2019, GPCR photopharmacology, Mol. Cell. Endocrinol., 488, 36, 10.1016/j.mce.2019.03.003 Laprell, 2017, Photopharmacological control of bipolar cells restores visual function in blind mice, J. Clin. Invest., 127, 2598, 10.1172/JCI92156 Tochitsky, 2018, Restoring vision to the blind with chemical photoswitches, Chem. Rev., 118, 10748, 10.1021/acs.chemrev.7b00723 Chemi, 2019, A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision, Future Med. Chem., 11, 463, 10.4155/fmc-2018-0315 Tochitsky, 2016, How azobenzene photoswitches restore visual responses to the blind retina, Neuron, 92, 100, 10.1016/j.neuron.2016.08.038 Bregestovski, 2018, Light-induced regulation of ligand-gated channel activity, Br. J. Pharmacol., 175, 1892, 10.1111/bph.14022 Sansalone, 2019, Chemical tuning of photoswitchable azobenzenes: a photopharmacological case study using nicotinic transmission, Beilstein J. Org. Chem., 15, 2812, 10.3762/bjoc.15.274 Lemoine, 2016, Optogenetic control of mammalian ion channels with chemical photoswitches, Methods Mol. Biol., 1408, 177, 10.1007/978-1-4939-3512-3_12 Damijonaitis, 2015, AzoCholine enables optical control of alpha 7 nicotinic acetylcholine receptors in neural networks, ACS Chem. Neurosci., 6, 701, 10.1021/acschemneuro.5b00030 Severin, 1963, Umsetzung von nitroaromaten mit natriumborhydrid, IV,, Chem. Ber., 96, 3076, 10.1002/cber.19630961134 Tan, 2005, An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization, J. Assoc. Lab. Autom., 10, 364, 10.1016/j.jala.2005.06.003 Bard, 2008, High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media, Eur. J. Pharmaceut. Sci., 33, 230, 10.1016/j.ejps.2007.12.002 Di, 2003, High throughput artificial membrane permeability assay for blood-brain barrier, Eur. J. Med. Chem., 38, 223, 10.1016/S0223-5234(03)00012-6 Fernández-Bachiller, 2012, New tacrine--4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties, J. Med. Chem., 55, 1303, 10.1021/jm201460y López-Iglesias, 2014, New melatonin--N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer’s disease, J. Med. Chem., 57, 3773, 10.1021/jm5000613 Estrada, 2016, New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties, Eur. J. Med. Chem., 121, 376, 10.1016/j.ejmech.2016.05.055 Estrada Valencia, 2018, Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease, Eur. J. Med. Chem., 156, 534, 10.1016/j.ejmech.2018.07.026 Estrada-Valencia, 2019, New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: multi-target-directed agents for Alzheimer’s disease endowed with neurogenic properties, J. Enzym. Inhib. Med. Chem., 34, 712, 10.1080/14756366.2019.1581184 Herrera-Arozamena, 2020, Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: discovery of QR2 ligands and NRF2 activators with neurogenic properties, Eur. J. Med. Chem., 190, 112090, 10.1016/j.ejmech.2020.112090 Denizot, 1986, Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J. Immunol. Methods, 89, 271, 10.1016/0022-1759(86)90368-6 Jiaranaikulwanitch, 2012, From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer’s disease, Molecules, 17, 8312, 10.3390/molecules17078312 Purohit, 2014, Catch-and-hold activation of muscle acetylcholine receptors having transmitter binding site mutations, Biophys. J., 107, 88, 10.1016/j.bpj.2014.04.057 Zuo, 2016, Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents, Bioorg. Med. Chem., 24, 179, 10.1016/j.bmc.2015.12.001 Russell, 1991, Electron transfer processes. 53. Homolytic alkylation of enamines by electrophilic radicals, J. Org. Chem., 56, 3475, 10.1021/jo00011a007 Rice, 2009 Molander, 2007, Aminomethylations via cross-coupling of potassium organotrifluoroborates with aryl bromides, Org. Lett., 9, 1597, 10.1021/ol070543e Tsou, 2010, Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo, 1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3(2H)-isoquinolones and methods of use thereof, US Patent, 7, 994 Lukas, 1986, Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671, J. Neurochem., 46, 1936, 10.1111/j.1471-4159.1986.tb08516.x Sharples, 2000, UB-165: a novel nicotinic agonist with subtype selectivity implicates the α4β2∗ subtype in the modulation of dopamine release from rat striatal synaptosomes, J. Neurosci., 20, 2783, 10.1523/JNEUROSCI.20-08-02783.2000 Gopalakrishnan, 1996, Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor, J. Pharmacol. Exp. Therapeut., 276, 289 Boland, 2009, Inhibitory effects of polyunsaturated fatty acids on Kv4/KChIP potassium channels, Am. J. Physiol. Cell Physiol., 296, C1003, 10.1152/ajpcell.00474.2008 Corbin-Leftwich, 2016, Retigabine holds KV7 channels open and stabilizes the resting potential, J. Gen. Physiol., 147, 229, 10.1085/jgp.201511517